Copyright
©The Author(s) 2025.
World J Gastrointest Pharmacol Ther. Sep 5, 2025; 16(3): 109046
Published online Sep 5, 2025. doi: 10.4292/wjgpt.v16.i3.109046
Published online Sep 5, 2025. doi: 10.4292/wjgpt.v16.i3.109046
Table 4 Effects of electroacupuncture on clinical, biological, and heart rate variability outcomes in irritable bowel syndrome with predominant constipation responders at baseline, post-treatment, and one-month follow-up
Outcome measures | IBS-C responders (n = 13) | P value | ||
Pre-treatment | Post-treatment | Follow-up | ||
Clinical score | ||||
IBS-SSS score | 280.00 (205.00-314.50) | 30.00a (0.00-85.00) | 45.00a (27.50-82.50) | < 0.001 |
IBS-QoL | 89.00 (77.00-103.00) | 55.50a (49.25-80.50) | 47.00a (44.00-56.50) | < 0.001 |
Memory part | ||||
MoCA | 25.30 ± 2.62 | 27.76 ± 1.69a | 28.00 ± 1.35a | < 0.001 |
MMSE | 26.76 ± 1.78 | 27.00 ± 1.58 | 27.53 ± 1.45 | 0.284 |
Emotional part | ||||
Anxiety | 9.30 ± 3.63 | 4.61 ± 2.18a | 5.08 ± 3.67a | < 0.001 |
Depression | 4.53 ± 2.53 | 2.76 ± 2.35 | 3.00 ± 3.16 | 0.060 |
Laboratory | ||||
Cortisol level (μg/dL) | 10.70 (8.60-14.45) | 12.30 (9.07-19.65) | 9.81 (7.65-18.30) | 0.774 |
MDA level (nmol/mL) | 382.75 ± 86.50 | 608.63 ± 141.19a | 484.17 ± 132.80 | < 0.001 |
Serotonin level (μg/dL) | 1.60 (0.62-2.78) | 2.86 (1.50-3.73) | 0.92 (0.77-2.23) | 0.251 |
Heart rate variability | ||||
LF | 22.08 ± 4.26 | 21.20 ± 5.51 | 20.16 ± 5.61 | 0.465 |
HF | 15.20 ± 5.07 | 14.24 ± 5.10 | 13.05 ± 4.56 | 0.398 |
LF/HF | 1.46 (1.26-1.53) | 1.54 (1.13-1.94) | 1.45 (1.34-1.81) | 0.833 |
- Citation: Yaklai K, Kunasol C, Suparan K, Apaijai N, Chitapanarux T, Pattanakuhar S, Chattipakorn N, Chattipakorn SC. Electroacupuncture alleviates symptoms and identifies a potential microbial biomarker in patients with constipation-predominant irritable bowel syndrome. World J Gastrointest Pharmacol Ther 2025; 16(3): 109046
- URL: https://www.wjgnet.com/2150-5349/full/v16/i3/109046.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v16.i3.109046